Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Wessex Academic Health Science Network | UNKNOWN |
| East Hampshire Better Local Care Fund | UNKNOWN |
| Pfizer | INDUSTRY |
| The Health Foundation |
Not provided
Not provided
Not provided
Not provided
Innovations aimed at improving new patient identification, diagnosis, nonpharmacological treatment, supported self-management, and remote monitoring, together with new methods of clinical support could improve outcomes in patients with respiratory disease. The Investigators have developed a model of care incorporating key innovations for patients with asthma, COPD and undifferentiated breathlessness. This service is being implemented within Wessex CCGs. The investigators will assess whether the implementation of the service is effective, and how it can be adjusted, in addition to introducing innovations to assess whether the expected benefits for patients are realised.
A combination of study designs are required to evaluate all aspects of the service:
Evaluation of the clinic cycles will include consideration of qualitative data from patients, carers and healthcare professionals, in addition to quantitative outcomes for service implementation and patient factors (i.e. uptake of the service and benefits realised in-session), including those in the following areas:
The longer-term impact of the service will be evaluated using clinical and health service outcomes such as:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MISSION ABC Integrated Care clinic | Other | The Investigators have developed a model of care incorporating key innovations for patients with asthma, COPD and undifferentiated breathlessness. This service is being implemented within Wessex CCGs. |
| Measure | Description | Time Frame |
|---|---|---|
| Acceptability of clinic process measured through the collection of qualitative feedback. | Qualitative feedback forms collected at ever clinical encounter, qualitative interviews at 3 months post clinic and HCP focus groups will generate qualitative data. This will be evaluated cyclically to inform changes in the clinic structure. | up to 18 months |
| Measure | Description | Time Frame |
|---|---|---|
| Number of changes in primary diagnosis or classification of disease severity resulting from a MISSION clinic appointment. | The number of new or changed diagnoses made as a result of a MISSION clinical encounter will be recorded. | 18 months |
| Number of additional co-morbid medical conditions identified from a MISSION clinical encounter. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All patients invited to a MISSION ABC clinic, all Healthcare Professionals attending.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Portsmouth Hospitals NHS Trust | Portsmouth | PO6 3LY | United Kingdom |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 38191248 | Derived | Heiden E, Longstaff J, Chauhan MJA, DeVos R, Lanning E, Neville D, Jones TL, Begum S, Amos M, Mottershaw M, Micklam J, Holdsworth B, Rupani H, Brown T, Chauhan AJ; Mission ABC Collaborators. MISSION ABC: transforming respiratory care through one-stop multidisciplinary clinics - an observational study. BMJ Open. 2024 Jan 8;14(1):e078947. doi: 10.1136/bmjopen-2023-078947. | |
| 36369507 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| OTHER |
Not provided
Not provided
Not provided
The number of co-morbid medical conditions identified by the medical team at a MISSION clinic will be recorded |
| 18 months |
| Frequency of uptake and attendance at the enhanced asthma education programme ESMENA | The number of patients invited to attend ESMENA who accept the invitation will be recorded. Attendance rates over each 3 sessions will be recorded. | 18 months |
| Changes in patients' perceived confidence in self-management before and after MISSION clinics and education sessions measured through questionnaire feedback | Patients will be asked to fill out a baseline questionnaire exploring their confidence in managing their disease and their health behaviours. They will be asked to rate confidence using a Liekrt scale that will be repeated at 3 and 6 months following their clinical or educational encounters. | 18 months |
| Uptake and acceptability of HCP education through the MISSION process | The numbers and grade of HCP who attend MISSION clinics and dedicated education sessions will be recorded. 10% attendees will be asked to participate in focus group interviews which will explore their beliefs around the value and acceptability of these educational opportunities. | 18 months |
| Number of patients where inhaler technique is improved at the first MISSION clinical encounter | Each patient will undergo an assessment of inhaler technique at their first appointment. Where education is required, it will be recorded if that intervention results in improvement. | 18 months |
| Number of referrals to the smoking cessation service embedded in the MISSION clinics that results in a quit attempt | Data will be extracted from the GP record to indicate if a quit attempt is made | 18 months |
| Any change in medication recorded | The number of new, changed or stopped prescriptions will be recorded. | 18 months |
| Number of triggers on remote monitoring that can be managed remotely | The number of patients using the Message Dynamics or Clinitouch remote monitoring systems who trigger a positive response on symptoms or observations where they can be managed via a supported call rather than a GP attendance will be recorded. Any suspected delay in reporting disease deterioration due to the presence of the remote monitoring systems will also be recorded. | 18 months |
| Number of additional secondary care referrals made as a result of the MISSION ABC process. | As a balancing measure, any secondary care referrals made will be recorded and additional costs to the healthcare system calculated. | 18 months |
| Change in disease-specific symptom control questionnaires from baseline to 3 and 6 months | CAT or ACQ will be measured at baseline and then 3 and 6 months to assess changes in symptom control | 6 months |
| Change in the productivity measure WPA from baseline to 3 and 6 months | Each patient will be asked to fill in the WPA at baseline, 3 and 6 months and the answers compared | 6 months |
| Change in the patient activation measure from baseline to 3 and 6 months. | Each patient will be asked to fill in the PAM at baseline, 3 and 6 months and the answers compared | 6 months |
| Changes in unscheduled health care usage per patient in the 12 months before and after MISSION ABC | For each patient the investigators will record their number of exacerbations, unscheduled GP visits, out-of-hours service calls, ED attendances and admissions in the 12 months before and 12 months after the MISSION clinic. | 24 months |
| Acceptability of each innovation measured | MISSION ABC incorporates several innovative diagnosis and treatment solutions: Thorasys oscillometry, Flo-Tone devices, Airsonett laminar airflow, my mHealth online education, Message Dynamics Remote Monitoring, Clinitouch remote monitoring. For each device patients will be asked to give qualitative feedback. | 18 months |
| Derived |
| Fox L, Heiden E, Chauhan MAJ, Longstaff JM, Balls L, De Vos R, Neville DM, Jones TL, Leung AW, Morrison L, Rupani H, Brown TP, Stores R, Chauhan AJ. Evaluation of telehealth support in an integrated respiratory clinic. NPJ Prim Care Respir Med. 2022 Nov 11;32(1):51. doi: 10.1038/s41533-022-00304-9. |
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| D001249 | Asthma |
| D004417 | Dyspnea |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001982 | Bronchial Diseases |
| D012130 | Respiratory Hypersensitivity |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |
| D012120 | Respiration Disorders |
| D012818 | Signs and Symptoms, Respiratory |
| D012816 | Signs and Symptoms |
Not provided
Not provided